III Capital Management »

Halozyme Therapeutics shares owned by III Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by III Capital Management from 13F filings

Historical chart of III Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by III Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by III Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $23M 24M 0.95
2024-03-31 $10M 11M 0.89
2023-03-31 $1.7M 2.0M 0.85

More positions owned by III Capital Management

Royal Caribbean Group Note 6.000% 8/1 (Principal)
Booking Holdings Note 0.750% 5/0 (Principal)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Ati Note 3.500% 6/1 (Principal)
Insight Enterprises Note 0.750% 2/1 (Principal)
Cyberark Software Note 11/1 (Principal)
Middleby Corp Note 1.000% 9/0 (Principal)
Ishares Tr Iboxx Inv Cp Etf Put Option (LQD)
Chart Inds Note 1.000%11/1 (Principal)
Block Note 0.125% 3/0 (Principal)
Southern Note 3.875%12/1 (Principal)
Etsy Note 0.125%10/0 (Principal)
Itron Note 3/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Guidewire Software Note 1.250% 3/1 (Principal)

View all positions for III Capital Management

Top funds holding Halozyme Therapeutics

Ing Investment Management
Invesco
Davidson Kempner Capital Management
Wellesley Investment Advisors
Lazard Asset Management
BlackRock
BlackRock
Calamos Advisors
III Capital Management
Shenkman Capital Management
Aviva
Advent Capital Management
CNH Partners
State Street Corporation
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Halozyme Therapeutics